Tiffany Olson - 01 Jul 2024 Form 4 Insider Report for CASTLE BIOSCIENCES INC (CSTL)

Role
Director
Signature
/s/ Frank Stokes, Attorney-in-fact
Issuer symbol
CSTL
Transactions as of
01 Jul 2024
Net transactions value
$0
Form type
4
Filing time
03 Jul 2024, 16:13:06 UTC
Previous filing
06 Jun 2024
Next filing
23 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CSTL Common Stock Options Exercise +830 +5.1% 17,233 01 Jul 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CSTL Restricted Stock Units Award $0 +830 $0.000000 830 01 Jul 2024 Common Stock 830 Direct F1
transaction CSTL Restricted Stock Units Options Exercise $0 -830 -100% $0.000000* 0 01 Jul 2024 Common Stock 830 Direct F1
transaction CSTL Stock option (right to buy) Award $0 +3,379 $0.000000 3,379 01 Jul 2024 Common Stock 3,379 $71.22 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Discretionary grants to address an administrative oversight following the issuer's 2021 annual meeting of stockholders where the filing person did not receive automatic annual grants in accordance with the issuer's nonemployee director compensation policy. Since the restricted stock units are payment in respect of 2021 compensation, they are subject to immediate vesting. Each unit converts into a share of common stock on a one-for-one basis.